SPS
ADPT icon

Susquehanna Portfolio Strategies’s Adaptive Biotechnologies ADPT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.19M Buy
374,269
+145,156
+63% +$2.31M 0.08% 295
2025
Q4 		$3.72M Hold
229,113
– – 0.06% 362
2025
Q3 		$3.43M Buy
229,113
+10,255
+5% +$125K 0.05% 382
2025
Q2 		$2.55M Buy
+218,858
New +$1.99M 0.06% 326
2024
Q1 		– Sell
-110,028
Closed -$539K – 782
2023
Q4 		$539K Buy
+110,028
New +$502K 0.01% 742

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna Portfolio Strategies's ADPT Position: Q1 2026 in Review

Susquehanna Portfolio Strategies increased its Adaptive Biotechnologies (ADPT) stake by 63% in Q1 2026, buying an estimated $2.31M and bringing the position to 374,269 shares worth $5.19M. The position accounts for 0.08% of the portfolio, ranked #295.

Susquehanna Portfolio Strategies first reported a position in ADPT in Q4 2023 and has held it in 5 quarters since. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Susquehanna Portfolio Strategies held 374,269 shares of Adaptive Biotechnologies worth $5.19M as of Q1 2026.
  • Susquehanna Portfolio Strategies bought 145,156 Adaptive Biotechnologies shares in Q1 2026, an estimated $2.31M.
  • Adaptive Biotechnologies made up 0.08% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #295 holding.
  • Susquehanna Portfolio Strategies first reported a position in Adaptive Biotechnologies in Q4 2023 and has held it in 5 quarters since.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.